Clinical Trials Browser

Terminated × OTHER × fedratinib × Clear all

NCT05127174 2025-12-04

Maintenance Fedratinib to Prevent Post-Transplant Relapse in Myeloproliferative Neoplasms

Phase 1 Terminated

Myeloproliferative Disorders

NCT05524857 2024-04-23

Combination of Fedratinib and Decitabine for Myeloproliferative Neoplasms (MPN)- Accelerated Phase (AP)/Blast Phase (BP)

Phase 1 Terminated

Blast Crisis, Myeloproliferative Disorders